strategic partnerships

The Scott Hamilton CARES Foundation strategically partners with organizations that enhance our mission dedicated to funding advanced, innovative research that treats the patient while sparing the patient. These partners are leading in non-invasive cancer treatments and cancer research. Our strategic partners are listed below.

Provision Logo (1).jpg

Our partner, Provision CARES Proton Therapy Nashville is a member of the Provision CARES Cancer Network and is the first cancer treatment center of its kind in Middle Tennessee.  It is also the first to offer proton therapy with Provision Healthcare’s ProNova SC360 technology.  This center provides the perfect combination of personalized, comprehensive patient care and leading-edge technology, offering one of the most advanced non-invasive cancer treatments in the world.

The Scott Hamilton CARES Foundation’s national headquarters is housed in this state-of-the-art facility, where our like-minded values to spare the patient harm are delivered through this advanced cancer treatment, which supports our mission.

The V Foundation.jpg

Our partner, The V Foundation, has funded over $225 million in research grants nationwide. Their Scientific Advisory Committee selects grant recipients through a highly competitive process working with the best and brightest minds in cancer research since it was established in 1993. The V Foundation gifts their Scientific Advisory Board to the Scott Hamilton CARES Foundation to vet the best precision targeted therapy research project(s) as part of our partnership. These vetted research grants are then considered for selection for CARES for funding in our mission of precision targeted therapies.

“We at the V Foundation are so grateful to the Scott Hamilton CARES Foundation for their tireless effort to raise funds and awareness for cutting- edge research for precision medicine,” said Susan Braun, CEO of the V Foundation for Cancer Research. A special thanks to the V Foundation for our partnership that allows CARES to invest in promising cancer research projects.